Literature DB >> 14966560

Fighting cancer by disrupting C-terminal methylation of signaling proteins.

Steven Clarke1, Fuyuhiko Tamanoi.   

Abstract

Protein methylation at the C-terminus of mammalian isoprenylated proteins has been implicated in membrane attachment, protein-protein interactions, and protein stability. A new paper describes surprising results: in the absence of methylation some target proteins have increased stability, whereas others have decreased stability. The decreased stability of the RhoA protein is correlated with an increased resistance to Ras-dependent transformation and suggests the basis for the development of a new approach to antitumor therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966560      PMCID: PMC338270          DOI: 10.1172/JCI21059

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Ras signalling on the endoplasmic reticulum and the Golgi.

Authors:  Vi K Chiu; Trever Bivona; Angela Hach; J Bernard Sajous; Joseph Silletti; Heidi Wiener; Ronald L Johnson; Adrienne D Cox; Mark R Philips
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

2.  Are prenyl groups on proteins sticky fingers or greasy handles?

Authors:  Anthony I Magee; Miguel C Seabra
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

3.  Cone photoreceptor betagamma-transducin: posttranslational modification and interaction with phosducin.

Authors:  Fayu Chen; Pei-San Ng; Kym F Faull; Rehwa H Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 4.  Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

Authors:  Thomas B Brunner; Stephen M Hahn; Anjali K Gupta; Ruth J Muschel; W Gillies McKenna; Eric J Bernhard
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

5.  A novel metal-chelating inhibitor of protein farnesyltransferase.

Authors:  Akiyuki Hamasaki; Hayato Naka; Fuyuhiko Tamanoi; Kazuo Umezawa; Masami Otsuka
Journal:  Bioorg Med Chem Lett       Date:  2003-05-05       Impact factor: 2.823

6.  Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation.

Authors:  Martin O Bergo; Patricia Ambroziak; Cria Gregory; Amanda George; James C Otto; Edward Kim; Hiroki Nagase; Patrick J Casey; Allan Balmain; Stephen G Young
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners.

Authors:  Richard K Gordon; Krzysztof Ginalski; Witold R Rudnicki; Leszek Rychlewski; Marvin C Pankaskie; Janusz M Bujnicki; Peter K Chiang
Journal:  Eur J Biochem       Date:  2003-09

8.  Automated identification of putative methyltransferases from genomic open reading frames.

Authors:  Jonathan E Katz; Mensur Dlakić; Steven Clarke
Journal:  Mol Cell Proteomics       Date:  2003-07-18       Impact factor: 5.911

9.  Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate.

Authors:  Ann M Winter-Vann; Barton A Kamen; Martin O Bergo; Stephen G Young; Stepan Melnyk; S Jill James; Patrick J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

10.  Studies on G-protein alpha.betagamma heterotrimer formation reveal a putative S-prenyl-binding site in the alpha subunit.

Authors:  Alexander Dietrich; Alexander Scheer; Daria Illenberger; Yoel Kloog; Yoav I Henis; Peter Gierschik
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

View more
  10 in total

1.  The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.

Authors:  Jessica L Anderson; Brian S Henriksen; Richard A Gibbs; Christine A Hrycyna
Journal:  J Biol Chem       Date:  2005-06-09       Impact factor: 5.157

2.  Isoprenylcysteine carboxyl methyltransferase facilitates glucose-induced Rac1 activation, ROS generation and insulin secretion in INS 832/13 β-cells.

Authors:  Bhavaani Jayaram; Ismail Syed; Alka Singh; Wasanthi Subasinghe; Chandrashekara N Kyathanahalli; Anjaneyulu Kowluru
Journal:  Islets       Date:  2011-03-01       Impact factor: 2.694

3.  A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.

Authors:  Ann M Winter-Vann; Rudi A Baron; Waihay Wong; June dela Cruz; John D York; David M Gooden; Martin O Bergo; Stephen G Young; Eric J Toone; Patrick J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-22       Impact factor: 11.205

4.  RHO methylation matters: a role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion.

Authors:  Ian Cushman; Patrick J Casey
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

5.  Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt).

Authors:  Rudi A Baron; Patrick J Casey
Journal:  BMC Biochem       Date:  2004-12-29       Impact factor: 4.059

6.  Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.

Authors:  Ian Cushman; Patrick J Casey
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

Review 7.  Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.

Authors:  Woo Seok Yang; Seung-Gu Yeo; Sungjae Yang; Kyung-Hee Kim; Byong Chul Yoo; Jae Youl Cho
Journal:  Amino Acids       Date:  2017-06-19       Impact factor: 3.520

8.  Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling.

Authors:  Wen Shen; Chao Gao; Ramon Cueto; Lu Liu; Hangfei Fu; Ying Shao; William Y Yang; Pu Fang; Eric T Choi; Qinghua Wu; Xiaofeng Yang; Hong Wang
Journal:  Redox Biol       Date:  2019-09-12       Impact factor: 11.799

Review 9.  Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.

Authors:  Shaila A Shetu; Debasish Bandyopadhyay
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 10.  Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins.

Authors:  Raymond R Mattingly
Journal:  ISRN Oncol       Date:  2013-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.